Screened 2026-08-20 · the tape above runs as of 16:37 UTC · 29 Aug · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its distribution label.
Infosys Ltd holds its Distribution at $11.83. Consolidating, no directional conviction, held for 3 days.
As held on the ledger · 2026-08-20
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 3 days
Price at the screen
$11.83
Valuation
14.60 trailing · 13.94 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.11
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
5.88%
Below 33%
Interest-bearing debt is just 5.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
14.23%
Below 33%
Cash held in interest-bearing accounts and securities is 14.2% of assets, under the one-third limit.
Pass
Receivables
1.96%
Below 49%
Money owed to the company is 2.0% of assets, under the 49% limit.
Pass
Revenue purity
0.23%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads OPPORTUNITY: it trades above our $10.62 fair value estimate, 2.90% revenue growth.
Fair value range in USD, drawn from the 2026-08-20 screen. The gold marker is the market price at the same screen. The price runs 10.3% above the base estimate.
Third-party analyst targets: 12 covering, consensus Hold. The average target sits −2% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-20 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Indian IT firm powering global digital shifts
Every time a bank in London upgrades its app or a retailer in New York moves data to the cloud, the work often lands with teams in Bangalore and Pune. Infosys sits at the centre of that flow, delivering consulting and digital services across continents. The business earns a 16% profit margin and turns equity at 31% a year, yet trades on a forward multiple of just 13 times earnings with revenue rising 7%.
Those numbers create a 16% margin of safety against our fair value of $13.32 while the stock sits at $11.49. The company passes our ethical screen, analysts lean buy with a median target at $13, and the steady cash flow from outsourcing contracts gives it resilience that pure software names often lack.
Currency swings, wage inflation in India and stiff competition from local rivals remain real threats that can clip margins without warning. Growth stays modest rather than explosive, so any slowdown in client spending would hit earnings quickly. Analysis, not advice.
The risks · The things to watch: its business and earnings are exposed to India and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
INFY trades on NYSE (ADR) (the company is based in India). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-02Markup · changed$11.70-0.3%Entry 4
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (12 analysts) rates it hold, with a mean price target of $15.
2026-07-18Distribution$11.74+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (12 analysts) rates it hold, with a mean price target of $15.
2026-07-03Distribution$11.74+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Distribution$11.74Entry 1
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
